EXTEND (Eltrombopag Extended Dosing Study)

Autores
Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2006
Cargando información sobre las referencias
An open-label, dose-adjustment, extension study to evaluate the safety and efficacy of eltrombopag for the treatment of subjects with idiopathic thrombocytopenic purpura (ITP) who have previously been enrolled in an eltrombopag trial. This study will allow adjustment of the eltrombopag dose to achieve an individualized dose and schedule for each subject. In addition, the ability to reduce the dose of concomitant ITP medications in the presence of eltrombopag, while maintaining platelet counts = 50,000/μL will be investigated.
Epistemonikos ID: ee5f009d3d44ba66663f23a6e0a1d5aca3107c76
First added on: May 04, 2024